Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Pediatric Oncology
What is the optimal salvage therapy for a patient with a relapsed primary mediastinal yolk sac tumor with brain metastases?
Optimal salvage chemotherapy?
Role/type of transplant?
Role for RT?
Role for surgery/neurosurgery?
Related Questions
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
In a patients with bilateral Wilms' tumor with favorable features (>90% response to VAD, no anaplasia), what histopathologic criteria should be used to define a positive margin requiring focal RT to a partial nephrectomy bed?
For patients with Stage IIIB or IV HD flowing Bv-AVEPC with initial large mediastinal adenopathy, how can we avoid ISRT?
How do you approach patients with osteosarcoma of the maxilla for neoadjuvant chemotherapy?
How do you differentiate demoralization from depression during cancer treatment?
How do you consider the role of probiotics for mucositis mitigation in patients receiving head and neck radiotherapy?
Would you offer adjuvant radiation therapy in a young adult with NF1 who has a craniopharyngioma s/p STR?
Does the use of and type of biopsy prior to therapy impact local relapse in Wilms?
Given the results of LU002 presented at ASCO 2024, are there situations and/or patient subgroups who still derive benefit from local consolidative therapy for oligometastatic NSCLC?
Do you recommend radioactive iodine for Hürthle Cell thyroid carcinoma?